Description

The talking points for these four segments are:

• Why are there so many options for pharmaceutical products?
• Do they offer hope in a capsule, bottle, or creams? 
• What control do pharmaceutical companies have over availability and access?
• Does variety add to consumer confusion and misinformation?
• How much information is provided through commercial advertisement? Who are some of the targeted audiences?
• What role do prescribing providers play in the education process? Ethical responsibility to the patient?
• At what point does a patient become a consumer - what are the ramifications for health maintenance?
• Cost - generic versus prescription? Over-the-Counter versus prescription? What’s in the name?
• Hypocrisy of use / Stigma of use
• Access biases - does this exist?

If body language and facial expressions are your thing, be sure to check out the video versions on youtube released the same day. 

It's been a great opportunity for us to learn and connect with so many colleagues, new listeners and friends!

--------------------------------------------------------------------------------------------------------------------- 

Check out our website: https://www.kingandeyelife.com/

Tune in live every 2nd and 4th Wednesday at 7:30 PM EST

YouTube: https://www.youtube.com/channel/UCVhB-H3kDEfgdUES1NC6aog 

Twitter: https://twitter.com/SoulTouchaPoet

Facebook: https://www.facebook.com/SunSoulX369

Follow us on all social media platforms: King & Eye Life Podcast

Support this podcast: Pay $KingAndEyeLife on Cash App

Riverside Link https://riverside.fm/?utm_campaign=campaign_1&utm_medium=affiliate&utm_source=rewardful&via=achieng

*Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use. No copyright infringement intended. ALL RIGHTS BELONG TO THEIR RESPECTIVE OWNERS*